← Leaderboards
Matthew Paul Spindler
Icahn School Of Medicine At Mount Sinai
$85,271
Attributed
$85,271
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $48.9K · FY2021–22$50K$37.5K$25K$12.5K$0
'21
'22
Funding mix
By agency
NIH$85,271 · 1
By mechanism
F30$85,271 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Jeremiah James Faith$16,695,707
- Michael A Silverman$4,264,765
- Sacha Gnjatic$20,887,220
- Saurabh Mehandru$4,728,229
- Huabao Xiong$3,138,286
Others in their field
Other Emerging Leaders on “Anaerobic Bacteria”
- Gary Fanger · Rise Therapeutics, Llc$3,144,956
- Seth Rakoff-Nahoum · Boston Children'S Hospital$2,972,605
- Robert Andrew Quinn · Michigan State University$2,653,163
- Jennifer Foulke-Abel · Johns Hopkins University$2,212,144
- David Noel O'Dwyer · University Of Michigan At Ann Arbor$1,936,226
- Chenggang Wu · University Of Texas Hlth Sci Ctr Houston$1,903,751
Research focus
Anaerobic BacteriaAntigensBacteriaBacterial CommunityBaseCellsCell TypeChronic Inflammatory DiseaseClinicColitisCollectionCommunitiesComplexCoupledEnzyme Linked Immunospot AssayExcisionExperimental StudyExposure ToFlow CytometryFrequenciesGenetic StudyGerm-FreeGnotobioticAdaptive Immune Response